Navy duffel bag, folded sweater and a small plant on a coffee table in a warm, sunlit living room
Company NewsAug 14, 20263 min read

Regenerative Revival Brings Concierge Stem Cell and Exosome Care to Patients' Homes

How Regenerative Revival combines physician-supervised, in-home regenerative care with nationwide telehealth for hormones, peptides, and NAD+, and how candidacy is decided.

Most people with joint pain follow a familiar path: rest, physical therapy, over-the-counter medication, injections, and eventually a conversation about surgery. Regenerative Revival was founded in 2018 by Seth Berge on the idea that people deserve to hear about additional options, and that learning about them shouldn't require a trip to a crowded waiting room.

What Regenerative Revival Does

Regenerative Revival is a concierge regenerative medicine company with a network of 100+ licensed clinicians. Its services fall into two groups:

  • •In-home regenerative care. For appropriate candidates, a licensed clinician administers Wharton's Jelly-derived stem cell and exosome therapy for joint and soft-tissue concerns at the patient's home, under physician oversight. In-home availability varies by location, so confirm coverage for your area when you inquire.
  • •Nationwide telehealth. Licensed clinicians prescribe and monitor bioidentical hormone therapy, clinician-led peptide protocols, and NAD+ therapy in all 50 states. Prescriptions are based on labs and a clinical review, and compounded medications are dispensed by accredited pharmacy partners.
  • Physician Oversight and Sourcing

    Every patient is overseen by Medical Director Dr. Sean Arora, CEO of Arora Health Group, which develops and supervises Regenerative Revival's protocols. Chief Medical Officer Dr. Shannon Arora leads the company's integrated-care approach, which keeps regenerative medicine, hormone therapy, and peptide protocols under one coordinated team and one patient record instead of spreading them across separate offices.

    Biological materials come from AATB-accredited tissue banks. Wharton's Jelly is the gelatinous connective tissue of the umbilical cord, collected with informed donor consent after healthy, full-term births. No embryonic tissue is used. You can read more on our Wharton's Jelly and exosome pages.

    Candidacy Is a Clinical Decision

    Not everyone is a candidate for regenerative therapy, and a consultation can end with a "no." Candidacy depends on factors such as the joint involved, imaging findings, prior treatments, medical history, and medications. If regenerative care isn't a fit, the clinician will say so and recommend appropriate next steps, which may include returning to your orthopedic specialist with a clearer picture of your options.

    What to Understand Before You Book

    Regenerative therapies are an evolving area of medicine, and it helps to go in with accurate expectations:

  • •The U.S. Food and Drug Administration has not approved any Wharton's Jelly-derived or exosome product for treating joint pain or arthritis. These products are considered investigational for musculoskeletal uses.
  • •Research is ongoing, and published studies vary in size and quality. Individual results vary, and no outcome is guaranteed.
  • •A reputable provider will explain this plainly before you decide anything. The FDA's consumer guidance on stem cell therapies and the ISSCR's patient resources are good places to read independently.
  • Start With a Conversation

    The easiest way to learn whether Regenerative Revival's approach fits your situation is the 2-minute consult quiz, which routes you to the right program. You can also contact the team with questions first.

    Ready to take the next step?

    Take The 2-Minute Quiz
    Related Articles